{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-106619","form_type":"8-K","ticker":"SRPT","cik":"0000873303","company_name":"Sarepta Therapeutics, Inc.","filed_at":"2024-09-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.101381+00:00","generated_at":"2026-05-31T04:49:16.430318+00:00","sec_items":["5.02","5.03","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Sarepta appoints Deirdre Connelly to board, increases board size to 9","bullets":["Deirdre Connelly appointed as Class I director effective Sept. 12, 2024, term through 2026 annual meeting.","Initial equity grant of $712,500 in value, split equally between RSUs and stock options.","Equity vests in three equal annual installments starting Sept. 12, 2025; annual cash retainer $60,000.","Board amended bylaws to increase maximum director limit from 8 to 9, effective immediately."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-106619","json":"https://secwatch.observer/filing/0000950170-24-106619.json","markdown":"https://secwatch.observer/filing/0000950170-24-106619.md","text":"https://secwatch.observer/filing/0000950170-24-106619.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/873303/000095017024106619/0000950170-24-106619-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/873303/000095017024106619/srpt-20240912.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T04:49:16.430318+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"53c179630f","claim":"Deirdre Connelly was appointed as Director at Sarepta Therapeutics, Inc..","evidence_excerpt":"On September 12, 2024, the board of directors (the “ Board ”) of Sarepta Therapeutics, Inc. (the “ Company ”) appointed Deirdre Connelly as a director of the Company, effective immediately, to serve as a member of Class I until the 2026 annual meeting of stockholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024106619/0000950170-24-106619-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}